These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 24887722)

  • 1. Time-dependent estimates of recurrence and survival in colon cancer: clinical decision support system tool development for adjuvant therapy and oncological outcome assessment.
    Steele SR; Bilchik A; Johnson EK; Nissan A; Peoples GE; Eberhardt JS; Kalina P; Petersen B; Brücher B; Protic M; Avital I; Stojadinovic A
    Am Surg; 2014 May; 80(5):441-53. PubMed ID: 24887722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical decision support and individualized prediction of survival in colon cancer: bayesian belief network model.
    Stojadinovic A; Bilchik A; Smith D; Eberhardt JS; Ward EB; Nissan A; Johnson EK; Protic M; Peoples GE; Avital I; Steele SR
    Ann Surg Oncol; 2013 Jan; 20(1):161-74. PubMed ID: 22899001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a Bayesian Belief Network Model for personalized prognostic risk assessment in colon carcinomatosis.
    Stojadinovic A; Nissan A; Eberhardt J; Chua TC; Pelz JO; Esquivel J
    Am Surg; 2011 Feb; 77(2):221-30. PubMed ID: 21337884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conventional adverse features do not predict response to adjuvant chemotherapy in stage II colon cancer.
    Peng SL; Thomas M; Ruszkiewicz A; Hunter A; Lawrence M; Moore J
    ANZ J Surg; 2014 Nov; 84(11):837-41. PubMed ID: 24224835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical impact of elastic laminal invasion in colon cancer: elastic laminal invasion-positive stage II colon cancer is a high-risk equivalent to stage III.
    Yokota M; Kojima M; Nomura S; Nishizawa Y; Kobayashi A; Ito M; Ochiai A; Saito N
    Dis Colon Rectum; 2014 Jul; 57(7):830-8. PubMed ID: 24901683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?
    Gill S; Loprinzi CL; Sargent DJ; Thomé SD; Alberts SR; Haller DG; Benedetti J; Francini G; Shepherd LE; Francois Seitz J; Labianca R; Chen W; Cha SS; Heldebrant MP; Goldberg RM
    J Clin Oncol; 2004 May; 22(10):1797-806. PubMed ID: 15067028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment and Survival of Small-bowel Adenocarcinoma in the United States: A Comparison With Colon Cancer.
    Young JI; Mongoue-Tchokote S; Wieghard N; Mori M; Vaccaro GM; Sheppard BC; Tsikitis VL
    Dis Colon Rectum; 2016 Apr; 59(4):306-15. PubMed ID: 26953989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating the adjuvant chemotherapy effect in elderly stage II and III colon cancer patients in an observational study.
    Kim KY; Cha IH; Ahn JB; Kim NK; Rha SY; Chung HC; Roh JK; Shin SJ
    J Surg Oncol; 2013 May; 107(6):613-8. PubMed ID: 23592499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. United States Military Cancer Institute Clinical Trials Group (USMCI GI-01) randomized controlled trial comparing targeted nodal assessment and ultrastaging with standard pathological evaluation for colon cancer.
    Nissan A; Protic M; Bilchik AJ; Howard RS; Peoples GE; Stojadinovic A
    Ann Surg; 2012 Sep; 256(3):412-27. PubMed ID: 22871988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A critical appraisal of treatment for T3N0 colon cancer.
    Yo IS; Opelka FG; Bolton JS; Fuhrman GM
    Am Surg; 2001 Feb; 67(2):143-8. PubMed ID: 11243538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The oncological outcome after right hemicolectomy and accuracy of CT scan as a preoperative tool for staging in right sided colonic cancers.
    Lim M; Hussain Z; Howe A; Storey R; Petty D; Haselden J; Sebag-Montefiore D; Alexander D
    Colorectal Dis; 2013 May; 15(5):536-43. PubMed ID: 23067005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemotherapy increase survival and decrease recurrence in stage IIA colon cancer.
    Yun HR; Kim HC; Yun SH; Lee WY
    Hepatogastroenterology; 2012; 59(120):2466-71. PubMed ID: 23169179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
    Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
    Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-dependent trends in lymph node yield and impact on adjuvant therapy decisions in colon cancer surgery: an international multi-institutional study.
    Stojadinovic A; Nissan A; Wainberg Z; Shen P; McCarter M; Protic M; Howard RS; Steele SR; Peoples GE; Bilchik A
    Ann Surg Oncol; 2012 Dec; 19(13):4178-85. PubMed ID: 22805869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved prediction of recurrence after curative resection of colon carcinoma using tree-based risk stratification.
    Radespiel-Tröger M; Hohenberger W; Reingruber B
    Cancer; 2004 Mar; 100(5):958-67. PubMed ID: 14983491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continued progress with stage III colorectal cancer--a triple cohort study.
    Lim M; Sharma P; Ing A; Blackburne H; Robinson B; Dixon L; Frampton C; Frizelle F
    N Z Med J; 2013 Sep; 126(1382):11-24. PubMed ID: 24154766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic hepatic arterial infusion chemotherapy for the prevention of liver metastasis in patients with colon carcinoma: a randomized control trial.
    Sadahiro S; Suzuki T; Ishikawa K; Yasuda S; Tajima T; Makuuchi H; Saitoh T; Murayama C
    Cancer; 2004 Feb; 100(3):590-7. PubMed ID: 14745877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omission of Adjuvant Chemotherapy Is Associated With Increased Mortality in Patients With T3N0 Colon Cancer With Inadequate Lymph Node Harvest.
    Wells KO; Hawkins AT; Krishnamurthy DM; Dharmarajan S; Glasgow SC; Hunt SR; Mutch MG; Wise P; Silviera ML
    Dis Colon Rectum; 2017 Jan; 60(1):15-21. PubMed ID: 27926553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydronephrosis as a prognostic factor in pelvic recurrence from rectal and colon carcinomas.
    Larsen SG; Wiig JN; Giercksky KE
    Am J Surg; 2005 Jul; 190(1):55-60. PubMed ID: 15972173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The surgeon as prognostic factor for local recurrence and survival in the anal sphincter preservation for mid-rectal cancer.
    Luna-Pérez P; Reyna Huelga A; Labastida Almendaro S; Rodríguez-Coria DF; González Macouzet J; Delgado Gallardo S
    Rev Invest Clin; 1999; 51(4):205-13. PubMed ID: 10546501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.